In view of the high cure rates of Trichomonas vaginitis after vaccination with the immunotherapeutic drug Solco Trichovac Gynatren, the therapeutic efficacy of this regimen in nonspecific vaginitis was investigated. 94 patients were treated in a multicentre study. Concurrent with a decrease of pathogens, the growth of a normal lactobacilli flora was observed. The degree of vaginal purity according to Schr?der and the vaginal pH returned to normal. A cure or at least a marked improvement of symptoms was documented in about 80% of patients. Compared to conventional forms of therapy, this regimen protects against reinfection, thus providing a decisive advantage.
Adult Aged